open.spotify.com/episode/2lFCJULjxhL150pmqKR5pG

Preview meta tags from the open.spotify.com website.

Linked Hostnames

1

Thumbnail

Search Engine Appearance

Google

https://open.spotify.com/episode/2lFCJULjxhL150pmqKR5pG

Reprogramming Immunity: How CCR5 Blockade Could Redefine Cancer Therapy

Listen to this episode from Rx for Biotech on Spotify. In this podcast episode, Dr. Jay Lalezari, CEO of CytoDyn Therapeutics, discusses the company's progress in developing a novel immunotherapy that targets the CCR5 receptor, one of the master immune cell regulators. Jay reviews some of the early clinical data with leronlimab, a first-in-class investigational monocolonal antibody that targets the CCR5 receptor and is being studied in metasatic triple-negative breast cancer and colorectal cancer.



Bing

Reprogramming Immunity: How CCR5 Blockade Could Redefine Cancer Therapy

https://open.spotify.com/episode/2lFCJULjxhL150pmqKR5pG

Listen to this episode from Rx for Biotech on Spotify. In this podcast episode, Dr. Jay Lalezari, CEO of CytoDyn Therapeutics, discusses the company's progress in developing a novel immunotherapy that targets the CCR5 receptor, one of the master immune cell regulators. Jay reviews some of the early clinical data with leronlimab, a first-in-class investigational monocolonal antibody that targets the CCR5 receptor and is being studied in metasatic triple-negative breast cancer and colorectal cancer.



DuckDuckGo

https://open.spotify.com/episode/2lFCJULjxhL150pmqKR5pG

Reprogramming Immunity: How CCR5 Blockade Could Redefine Cancer Therapy

Listen to this episode from Rx for Biotech on Spotify. In this podcast episode, Dr. Jay Lalezari, CEO of CytoDyn Therapeutics, discusses the company's progress in developing a novel immunotherapy that targets the CCR5 receptor, one of the master immune cell regulators. Jay reviews some of the early clinical data with leronlimab, a first-in-class investigational monocolonal antibody that targets the CCR5 receptor and is being studied in metasatic triple-negative breast cancer and colorectal cancer.

  • General Meta Tags

    15
    • title
      Reprogramming Immunity: How CCR5 Blockade Could Redefine Cancer Therapy - Rx for Biotech | Podcast on Spotify
    • charset
      utf-8
    • X-UA-Compatible
      IE=9
    • viewport
      width=device-width, initial-scale=1
    • fb:app_id
      174829003346

  • Open Graph Meta Tags

    154
    • og:site_name
      Spotify
    • og:title
      Reprogramming Immunity: How CCR5 Blockade Could Redefine Cancer Therapy
    • og:description
      Rx for Biotech · Episode
    • og:url
      https://open.spotify.com/episode/2lFCJULjxhL150pmqKR5pG
    • og:type
      music.song

  • Twitter Meta Tags

    5
    • twitter:site
      @spotify
    • twitter:title
      Reprogramming Immunity: How CCR5 Blockade Could Redefine Cancer Therapy
    • twitter:description
      Rx for Biotech · Episode
    • twitter:image
      https://i.scdn.co/image/ab6765630000ba8a34865c45d0a64ae63fc436d7
    • twitter:card
      summary

  • Link Tags

    31
    • alternate
      https://open.spotify.com/oembed?url=https%3A%2F%2Fopen.spotify.com%2Fepisode%2F2lFCJULjxhL150pmqKR5pG
    • alternate
      android-app://com.spotify.music/spotify/episode/2lFCJULjxhL150pmqKR5pG
    • canonical
      https://open.spotify.com/episode/2lFCJULjxhL150pmqKR5pG
    • icon
      https://open.spotifycdn.com/cdn/images/favicon32.b64ecc03.png
    • icon
      https://open.spotifycdn.com/cdn/images/favicon16.1c487bff.png

  • Website Locales

    2
    • EN country flagen
      https://open.spotify.com/episode/2lFCJULjxhL150pmqKR5pG
    • DEFAULT country flagx-default
      https://open.spotify.com/episode/2lFCJULjxhL150pmqKR5pG

Links

6